Natural Heart Health Supplement Trial

Phase 1

Not yet recruiting

• Conditions: Cholesterol; Cholesterol (total and HDL)

• Registration Number: NCT06671769
• Lead Sponsor: Efforia, Inc

Brief Summary

We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).

Detailed Description

Heart disease is a leading cause of death in the United States, and maintaining healthy cholesterol levels is crucial for heart health. While social media and the press have focused on trendier treatments for general longevity, for most of us keeping our cholesterol in check will make a major impact. Research indicates that natural substances long used in Eastern medicine, can positively affect cholesterol levels and reduce inflammation, both vital for cardiovascular wellness.

This study aims to empower participants with evidence-based insights about the effectiveness of a natural heart health supplement in managing cholesterol levels and reducing inflammation. By participating, you'll contribute to valuable research while potentially enhancing your heart health through natural means.

This study aims to assess the impact of a natural heart health supplement on Total Cholesterol, HDL-C, LDL-C, Triglycerides, and hs-CRP levels over three months. Our objective is to provide evidence supporting or refuting the supplement's efficacy.

Study Timeline

• Study First Submitted: 2024-10-28
• Status Verified: 2024-11
• Study First Submitted QC: 2024-11-01
• Last Update Submitted: 2024-11-01
• Study First Posted: 2024-11-04
• Last Update Posted: 2024-11-04
• Study Start: 2025-01-15
• Primary Completion: 2025-04-30
• Study Completion: 2025-05-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

• Individuals with known soy allergies
• Individuals with liver disease
• Pregnant or breastfeeding individuals

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Total Cholesterol	from Baseline to 30 day and 90 day.	Total Cholesterol as measured by an at-home blood collection kit returned to the lab
HDL Cholesterol	from baseline to 30 day and 90 day	as measured by an at-home blood collection kit returned to the lab
LDL Cholesterol	Baseline to 30 day and 90 day	as measured by an at-home blood collection kit returned to the lab
Triglycerides	From baseline to 30 day and 90 day	as measured by at-home blood collection returned to lab

Secondary Outcome Measures

Name	Time	Method
hs-CRP	from baseline to 30 day and 90 day	as measured by at-home blood test returned to a lab.

Trial Locations

Locations (1)

Efforia - Study will be entirely online; 🇺🇸 New York, New York, United States